Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.76 in the prior trading day, Editas Medicine Inc (NASDAQ: EDIT) closed at $3.29, down -12.50%. In other words, the price has decreased by -$12.50 from its previous closing price. On the day, 3.32 million shares were traded. EDIT stock price reached its highest trading level at $3.75 during the session, while it also had its lowest trading level at $3.23.
Ratios:
Our goal is to gain a better understanding of EDIT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.85. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on August 08, 2024, Upgraded its rating to Buy and sets its target price to $15 from $13 previously.
On May 09, 2024, Morgan Stanley Upgraded its rating to Equal-Weight which previously was Underweight but kept the price unchanged to $7.
Citigroup Upgraded its Neutral to Buy on October 24, 2023, while the target price for the stock was maintained at $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 04 ’24 when Mei Baisong sold 518 shares for $3.42 per share. The transaction valued at 1,774 led to the insider holds 133,895 shares of the business.
O’Neill Gilmore Neil sold 1,555 shares of EDIT for $5,325 on Sep 04 ’24. The CEO now owns 313,724 shares after completing the transaction at $3.42 per share. On Sep 03 ’24, another insider, O’Neill Gilmore Neil, who serves as the Officer of the company, bought 3,000 shares for $3.92 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 271347360 and an Enterprise Value of 69697400. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05 while its Price-to-Book (P/B) ratio in mrq is 1.17. Its current Enterprise Value per Revenue stands at 1.04 whereas that against EBITDA is -0.336.
Stock Price History:
Over the past 52 weeks, EDIT has reached a high of $11.69, while it has fallen to a 52-week low of $2.91. The 50-Day Moving Average of the stock is -8.58%, while the 200-Day Moving Average is calculated to be -43.04%.
Shares Statistics:
The stock has traded on average 1.81M shares per day over the past 3-months and 1980010 shares per day over the last 10 days, according to various share statistics. A total of 81.77M shares are outstanding, with a floating share count of 81.70M. Insiders hold about 0.94% of the company’s shares, while institutions hold 67.10% stake in the company. Shares short for EDIT as of 1727654400 were 16741192 with a Short Ratio of 9.23, compared to 1724976000 on 18005727. Therefore, it implies a Short% of Shares Outstanding of 16741192 and a Short% of Float of 25.72.
